Presentation is loading. Please wait.

Presentation is loading. Please wait.

Asthma Control and Expectations (ACE study)

Published by순재 애 Modified over 5 years ago

Similar presentations

Presentation on theme: "Asthma Control and Expectations (ACE study)"— Presentation transcript:

1 Asthma Control and Expectations (ACE study)
Asthma Control and Expectations (ACE study). a) Proportion of respondents (n = 1031) with daily asthma symptoms; difference in symptom frequency between patients who report feeling well (n = 415) compared with those who report feeling unwell (n = 472). ▪: w... Asthma Control and Expectations (ACE study). a) Proportion of respondents (n = 1031) with daily asthma symptoms; difference in symptom frequency between patients who report feeling well (n = 415) compared with those who report feeling unwell (n = 472). ▪: wheeziness; : tight chest; &boxDl: cough; □: breathlessness. (b) Restrictions on lifestyle in asthma; proportion of patients who report these limitations. ▪: experienced restrictions; ░: discussed restriction with general practitioner; □: discussed restriction with practice nurse. Reprinted with permission from Gruffydd-Jones [2]. P. Barnes et al. Eur Respir Rev 2005;14: ©2005 by European Respiratory Society

Download ppt "Asthma Control and Expectations (ACE study)"

Similar presentations

Patients who had reported experiencing symptoms in the previous 7 days were asked during what times of the day the symptoms were most troublesome. a) Breathlessness,

Patients who had reported experiencing symptoms in the previous 7 days were asked during what times of the day the symptoms were most troublesome. a) Breathlessness,
Radiology assessment of pulmonary amyloidosis

Radiology assessment of pulmonary amyloidosis
In chronic haemorrhage a) several pigmented macrophages fill the alveoli with dense fibrosis of the interstitium; b) the haemosiderin pigment in macrophages.

In chronic haemorrhage a) several pigmented macrophages fill the alveoli with dense fibrosis of the interstitium; b) the haemosiderin pigment in macrophages.
Flowchart showing the requirement for starting, documenting and evaluating the effect on quality of life (QoL) of interdisciplinary best supportive care.

Flowchart showing the requirement for starting, documenting and evaluating the effect on quality of life (QoL) of interdisciplinary best supportive care.
Familial history of hereditary haemorrhagic telangiectasis (HHT) of the 29-yr-old patient (•) with HHT and severe pulmonary arterial hypertension (PAH).

Familial history of hereditary haemorrhagic telangiectasis (HHT) of the 29-yr-old patient (•) with HHT and severe pulmonary arterial hypertension (PAH).
A) Peak forced expiratory volume in 1 s within 3 h post-dosing (peak FEV10–3h) response following once-daily tiotropium Respimat add-on to medium-dose.

A) Peak forced expiratory volume in 1 s within 3 h post-dosing (peak FEV10–3h) response following once-daily tiotropium Respimat add-on to medium-dose.
High-resolution chest computed tomography images of a patient with lymphangioleiomyomatosis, showing round-shaped, thin-walled cysts distributed diffusely.

High-resolution chest computed tomography images of a patient with lymphangioleiomyomatosis, showing round-shaped, thin-walled cysts distributed diffusely.
Oesophageal pleural fistula in a patient with Crohn's disease

Oesophageal pleural fistula in a patient with Crohn's disease
High-resolution computed tomography scan revealing a nonspecific interstitial pneumonia pattern with basal predominant ground-glass opacities and associated.

High-resolution computed tomography scan revealing a nonspecific interstitial pneumonia pattern with basal predominant ground-glass opacities and associated.
Occurrence of morning symptoms

Occurrence of morning symptoms
a) Chest radiograph showing bilateral coarse interstitial shadowing

a) Chest radiograph showing bilateral coarse interstitial shadowing
Closed pleural biopsy. a) Example of a core-biopsy cutting needle

Closed pleural biopsy. a) Example of a core-biopsy cutting needle
Changes in operating lung volumes expressed as % of predicted total lung capacity (%TLC predicted) are shown as minute ventilation (V′E) increases during.

Changes in operating lung volumes expressed as % of predicted total lung capacity (%TLC predicted) are shown as minute ventilation (V′E) increases during.
Treatment algorithm for managing chronic thromboembolic pulmonary hypertension (CTEPH), from the European Society of Cardiology/European Respiratory Society.

Treatment algorithm for managing chronic thromboembolic pulmonary hypertension (CTEPH), from the European Society of Cardiology/European Respiratory Society.
Kaplan–Meier analysis of survival over 2 years of treatment with riociguat in the CHEST-2 study [54]. Kaplan–Meier analysis of survival over 2 years of.

Kaplan–Meier analysis of survival over 2 years of treatment with riociguat in the CHEST-2 study [54]. Kaplan–Meier analysis of survival over 2 years of.
Extent of interstitial lung disease (ILD) in patients with systemic sclerosis-associated ILD. A simple stratification that utilises pulmonary function.

Extent of interstitial lung disease (ILD) in patients with systemic sclerosis-associated ILD. A simple stratification that utilises pulmonary function.
Representative diaphragm electromyogram (EMG) tracings at rest (a and b) and during maximum voluntary ventilation (c and d) in a healthy subject (a and.

Representative diaphragm electromyogram (EMG) tracings at rest (a and b) and during maximum voluntary ventilation (c and d) in a healthy subject (a and.
Computed tomography coronary angiogram from a 43-year-old female patient with pulmonary arterial hypertension, showing compression of the left coronary.

Computed tomography coronary angiogram from a 43-year-old female patient with pulmonary arterial hypertension, showing compression of the left coronary.
Effect of inspiratory rate on respirable particles generated from different inhalation devices. ———: budesonide Turbuhaler® (AstraZeneca, Draco, Sweden;

Effect of inspiratory rate on respirable particles generated from different inhalation devices. ———: budesonide Turbuhaler® (AstraZeneca, Draco, Sweden;
Serial computed tomography (CT) imaging for monitoring disease progression in patients with idiopathic pulmonary fibrosis. Serial computed tomography (CT)

Serial computed tomography (CT) imaging for monitoring disease progression in patients with idiopathic pulmonary fibrosis. Serial computed tomography (CT)

Similar presentations

Ads by Google